Search filters

List of works by Irina Cleemput

A comparative study of European rare disease and orphan drug markets ⬇️

scientific article published on June 17, 2010

A multi-criteria decision approach for ranking unmet needs in healthcare

scientific article published on 30 June 2018

A review of the literature on the economics of noncompliance. Room for methodological improvement

scientific article

A social preference valuations set for EQ-5D health states in Flanders, Belgium

scientific article published on 7 July 2009

Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders

scientific article published on 18 February 2015

An evaluation of managed entry agreements in Belgium: A system with threats and (high) potential if properly applied

scientific article published on 18 June 2020

An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?

scientific article published on 30 July 2020

Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities

scientific article published on 22 March 2013

Assessing cancer patients' quality of life and supportive care needs: Translation-revalidation of the CARES in Flemish and exhaustive evaluation of concurrent validity

scientific article

Balancing evidence and public opinion in health technology assessments: the case of leukoreduction

scientific article published on 01 January 2006

Barriers and facilitators related to the implementation of surgical safety checklists: a systematic review of the qualitative evidence.

scientific article published on 21 July 2015

Belgian guidelines for economic evaluations: second edition

scientific article published on December 2014

Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests

scientific article

Budget impact analysis of orphan drugs in Belgium: estimates from 2008 to 2013.

scientific article published on January 2010

Calculating an intervention's (cost-)effectiveness for the real-world target population: The potential of combining strengths of both RCTs and observational data ⬇️

scientific article published on May 16, 2012

Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU

scientific article published on 01 January 2012

Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesity

scientific article published on 01 January 2008

Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium

scientific article published on 01 January 2009

Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening

scientific article published in April 2009

Critical assessment of belgian reimbursement dossiers of orphan drugs

scientific article published in October 2011

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study

scientific article published on 03 December 2019

Developing an agency's position with respect to patient involvement in health technology assessment: the importance of the organizational culture

scientific article published on 02 October 2020

Developing the HTA core model for the online environment

scientific article published in November 2014

EXPLORING VALUES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES USING REFLECTIVE MULTICRITERIA AND RARE DISEASE CASE.

scientific article published on 11 October 2017

Economic evaluation of the use of point-of-care devices in patients with long term oral anticoagulation ⬇️

scientific article published on October 1, 2012

Economic implications of non-compliance in health care

scientific article published on 01 June 2002

Endpoints for relative effectiveness assessment (REA) of pharmaceuticals

scientific article published on 01 November 2014

European drug reimbursement systems' legitimacy: five-country comparison and policy tool

scientific article

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US

scientific article published on 18 September 2019

Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review

scientific article published on 26 September 2018

Gender and educational differences in the association between smoking and health-related quality of life in Belgium.

scientific article

Giving Patients' Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public-Private Project

scientific article published on 28 February 2017

Harmonization of ethics in health technology assessment: a revision of the Socratic approach

scientific article published in January 2014

Harmonizing HTA

scientific article published on 01 April 2010

Health professionals' perceptions of health status after renal transplantation: a comparison with transplantation candidates' expectations

scientific article published on 01 July 2003

History of health technology assessment in Belgium

scientific article

Infection prevention and control strategies in the era of limited resources and quality improvement: a perspective paper

scientific article published on 19 August 2013

Issues Surrounding Orphan Disease and Orphan Drug Policies in Europe

Making health continuous: implications of different methods on the measurement of inequality

scientific article published on 01 January 2006

Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date

scientific article published on January 2007

Methodology for calculating a country's need for positron emission tomography scanners

scientific article published in January 2008

Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward

scientific article published on 16 October 2019

Noncompliance with immunosuppressive regimen in organ transplantation: is it worth worrying about?

scientific article

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

scientific article published on 04 October 2019

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA

scientific article published on 01 October 2019

Pharmaceutical regulation in 15 European countries review

scientific article published on October 2016

Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review

scientific article

Re-scaling social preference data: implications for modelling

scientific article

Revealing and acknowledging value judgments in health technology assessment

scientific article published in December 2014

Similarities and differences between five European drug reimbursement systems ⬇️

scientific article published on September 19, 2012

Stimulating pharmaceutical innovation in the EU ⬇️

scientific article published on 01 June 2011

Testing the HTA core model: experiences from two pilot projects

scientific article published on 01 December 2009

The construct and concurrent validity of the EQ-5D in a renal transplant population.

scientific article published in July 2004

The determinants of defensive medicine practices in Belgium

scientific article published on 22 November 2016

The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis

scientific article published in September 2005

The economic implications of non-adherence after renal transplantation

scientific article published on 01 January 2004

The impact of no-fault compensation on health care expenditures: an empirical study of OECD countries

scientific article published on 28 September 2014

Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines

scientific article published on 20 December 2017

Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions ⬇️

scientific article published on January 25, 2011

Valorising and creating access to innovative medicines in the European union

scientific article

Which quality of life measures fit your relative effectiveness assessment?

scientific article published on January 2015

[Orphan diseases and orphan medicines: a Belgian and European study]

scientific article published on 01 December 2009

Paulina is supported by:

About Paulina

Help